Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B

BACKGROUND: Various treatment combinations of peginterferon (PEG‐IFN) and nucleos(t)ide analogues have been evaluated for chronic hepatitis B (CHB), but the optimal regimen remains unclear. AIMS: To study whether PEG‐IFN add‐on increases response compared to entecavir (ETV) monotherapy, and whether...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Aliment Pharmacol Ther
Main Authors: Liem, Kin Seng, van Campenhout, Margo J. H., Xie, Qing, Brouwer, Willem Pieter, Chi, Heng, Qi, Xun, Chen, Liang, Tabak, Fehmi, Hansen, Bettina E., Janssen, Harry L. A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Hepb Sag and Hbv DNA Predict Response to Pegylated Interferon plus Entecavir
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590282/
https://ncbi.nlm.nih.gov/pubmed/30689258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15098
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados